Evaluation of perinuclear anit-neutrophil cytoplasmic antibodies (pANCA), anti-saccharomyces cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease and ulcerative colitis

Sandborn, W; Loftus, E; Kaul, D; Zinsmeister, A; Tremaine, W; Homburger, H; Colombel, J; Sendid, B; Chapman, R; Fleming, K; Seibold, F; Targan, SR

Journal article

Evaluation of perinuclear anit-neutrophil cytoplasmic antibodies (pANCA), anti-saccharomyces cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease and ulcerative colitis

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Sandborn, W., Loftus, E., Kaul, D., Zinsmeister, A., Tremaine, W., Homburger, H., Colombel, J., Sendid, B., Chapman, R., Fleming, K., Seibold, F., & Targan, S. R. (1999). Evaluation of perinuclear anit-neutrophil cytoplasmic antibodies (pANCA), anti-saccharomyces cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease and ulcerative colitis. GASTROENTEROLOGY, 116(4), A811–A811.

MLA Style

Sandborn, W, et al. “Evaluation of Perinuclear Anit-Neutrophil Cytoplasmic Antibodies (PANCA), Anti-Saccharomyces Cerevisiae (ASCA), and Anti-Pancreatic Antibodies (APA) as Serologic Markers in a Population Based Cohort of Patients with Crohn's Disease and Ulcerative Colitis.” GASTROENTEROLOGY, vol. 116, no. 4, 1999, pp. A811–A811.

Chicago Style

Sandborn, W, E Loftus, D Kaul, et al. 1999. “Evaluation of Perinuclear Anit-Neutrophil Cytoplasmic Antibodies (PANCA), Anti-Saccharomyces Cerevisiae (ASCA), and Anti-Pancreatic Antibodies (APA) as Serologic Markers in a Population Based Cohort of Patients with Crohn's Disease and Ulcerative Colitis.” GASTROENTEROLOGY 116 (4): A811–A811.
Print